Alendronate is in a class of drugs called bisphosphonates used to prevent and treat certain types of bone loss (osteoporosis) in adults.

The global Alendronate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Alendronate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alendronate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Merck
Teva
Mylan
Apotex
Pfizer
Novartis
Eli Lilly
Amgen
Tecoland
Taj Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
5 mg Tablets
10 mg Tablets
35 mg Tablets
70 mg Tablets

Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis